This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako Kyoto

Jerome Boyd-Kirkup
Co-Founder & CSO at Hummingbird Bioscience, Singapore
Speaker

Profile

Jerome Boyd-Kirkup is Chief Scientific Officer and co-founder of Hummingbird Bioscience where he oversees research and the drug pipeline. Jerome’s career has focused on tackling human disease by applying systems biology approaches. Jerome is also Chief Scientific Officer and co-founder of Callio Therapeutics. A molecular biologist by background with extensive experience in computational and wet lab biology, Jerome holds a Bachelor’s and Master’s degree in Biochemistry from Imperial College London and a PhD in Molecular Biology from Cambridge University.

Agenda Sessions

  • Novel, next-generation ADCs for autoimmune and inflammatory diseases

    10:00